Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maqin Kechuan Heji is a Traditional Chinese Medicine (TCM) oral liquid formulation developed primarily for the treatment of respiratory conditions such as acute and chronic bronchitis, bronchial asthma, and cough associated with "lung heat" patterns. The preparation is notably associated with the Gansu Provincial Hospital of Traditional Chinese Medicine. Its pharmacological profile is derived from a combination of herbal ingredients, including *Ephedra sinica*, which provides sympathomimetic bronchodilation via beta-adrenergic stimulation, and *Scutellaria baicalensis*, which exerts anti-inflammatory and anti-pyretic effects by inhibiting inflammatory cytokines and enzymes like cyclooxygenase. The mixture is designed to clear heat, resolve phlegm, and alleviate wheezing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Maqin Kechuan Heji.